A pilot study to monitor changes in spirometry and lung volume, following an exacerbation of Chronic Obstructive Pulmonary Disease (COPD), as part of a supported discharge program

Respiratory Medicine

Volumn 119, Issue , 2016, Pages 55-62

  Cushen, Breda ^a   McCormack, Niamh ^a   Hennigan, Kerrie ^a   Sulaiman, Imran ^a   Costello, Richard W ^a   Deering, Brenda ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Acute exacerbation of COPD; Chronic Obstructive Pulmonary Disease (COPD); COPD re exacerbation; Hospital at home

Indexed keywords

ACCELEROMETER; ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; DISEASE EXACERBATION; FEMALE; FORCED VITAL CAPACITY; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT MONITORING; PILOT STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SPIROMETRY; COMPLICATION; EPIDEMIOLOGY; EXERCISE; FORCED EXPIRATORY VOLUME; HOME CARE; HOSPITAL READMISSION; IRELAND; LUNG; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; STANDARDS; STATISTICS AND NUMERICAL DATA; UTILIZATION; VITAL CAPACITY;

AGED; DISEASE PROGRESSION; EXERCISE; FEMALE; FORCED EXPIRATORY VOLUME; HOME CARE SERVICES; HUMANS; IRELAND; LUNG; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT DISCHARGE; PATIENT READMISSION; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPIROMETRY; VITAL CAPACITY;

EID: 84984623427     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2016.08.019     Document Type: Article

References (29)

1. [1] (WHO) WHO. Global surveillance, prevention and control of chronic respiratory diseases : a comprehensive approach/Jean Bousquet and Nikolai Khaltaev editors.
2. [2] Mathers, C.D., Loncar, D., Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med., 3(11), 2006, e442.
3. [3] Donaldson, G.C., Seemungal, T.A., Bhowmik, A., Wedzicha, J.A., Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 57:10 (2002), 847–852.
4. [4] Pitta, F., Troosters, T., Probst, V.S., Spruit, M.A., Decramer, M., Gosselink, R., Physical activity and hospitalization for exacerbation of COPD. Chest 129:3 (2006), 536–544.
5. [5] Gimeno-Santos, E., Frei, A., Steurer-Stey, C., de Batlle, J., Rabinovich, R.A., Raste, Y., et al. Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax 69:8 (2014), 731–739.
6. [6] Borges, R.C., Carvalho, C.R., Physical activity in daily life in Brazilian COPD patients during and after exacerbation. Copd 9:6 (2012), 596–602.
7. [7] Almagro, P., Calbo, E., Ochoa de Echaguen, A., Barreiro, B., Quintana, S., Heredia, J.L., et al. Mortality after hospitalization for COPD. Chest 121:5 (2002), 1441–1448.
8. [8] Chu, C.M., Chan, V.L., Lin, A.W., Wong, I.W., Leung, W.S., Lai, C.K., Readmission rates and life threatening events in COPD survivors treated with non-invasive ventilation for acute hypercapnic respiratory failure. Thorax 59:12 (2004), 1020–1025.
9. [9] European Respiratory Society European Lung White Book. 2011.
10. [10] Hurst, J.R., Donaldson, G.C., Quint, J.K., Goldring, J.J., Baghai-Ravary, R., Wedzicha, J.A., Temporal clustering of exacerbations in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 179:5 (2009), 369–374.
11. [11] Royal College of Physicians of London, British Thoracic Society, Foundation BL. Report of The National Chronic Obstructive Pulmonary Disease Audit 2008:clinical audit of COPD exacerbations admitted to acute NHS units across the UK 2008.
12. [12] Davies, L., Wilkinson, M., Bonner, S., Calverley, P.M., Angus, R.M., Hospital at home″ versus hospital care in patients with exacerbations of chronic obstructive pulmonary disease: prospective randomised controlled trial. Bmj 321:7271 (2000), 1265–1268.
13. [13] British Thoracic Society, Intermediate care–Hospital-at-Home in chronic obstructive pulmonary disease: British Thoracic Society guideline. Thorax 62:3 (2007), 200–210.
14. [14] Sapey, E., Stockley, R.A., COPD exacerbations · 2: Aetiology. Thorax 61:3 (2006), 250–258.
15. [15] Stevenson, N.J., Walker, P.P., Costello, R.W., Calverley, P.M.A., Lung mechanics and dyspnea during exacerbations of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 172:12 (2005), 1510–1516.
16. [16] Parker, C.M., Voduc, N., Aaron, S.D., Webb, K.A., O'Donnell, D.E., Physiological changes during symptom recovery from moderate exacerbations of COPD. Eur. Respir. J. 26:3 (2005), 420–428.
17. [17] Celli, B.R., MacNee, W., Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur. Respir. J. 23:6 (2004), 932–946.
18. [18] Borg, G.A., Psychophysical bases of perceived exertion. Med. Sci. sports Exerc. 14:5 (1982), 377–381.
19. [19] Miller, M.R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., et al. Standardisation of spirometry. Eur. Respir. J. 26:2 (2005), 319–338.
20. [20] Waschki, B., Kirsten, A.M., Holz, O., Mueller, K.C., Schaper, M., Sack, A.L., et al. Disease progression and changes in physical activity in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 192:3 (2015), 295–306.
21. [21] Kon, S.S., Canavan, J.L., Jones, S.E., Nolan, C.M., Clark, A.L., Dickson, M.J., et al. Minimum clinically important difference for the COPD Assessment Test: a prospective analysis. Lancet Respir. Med. 2:3 (2014), 195–203.
22. [22] Murphy, P.B., Kumar, A., Reilly, C., Jolley, C., Walterspacher, S., Fedele, F., et al. Neural respiratory drive as a physiological biomarker to monitor change during acute exacerbations of COPD. Thorax 66:7 (2011), 602–608.
23. [23] Suh, E.S., Mandal, S., Harding, R., Ramsay, M., Kamalanathan, M., Henderson, K., et al. Neural respiratory drive predicts clinical deterioration and safe discharge in exacerbations of COPD. Thorax 70:12 (2015), 1123–1130.
24. [24] Gonzalez, C., Servera, E., Marin, J., Importance of noninvasively measured respiratory muscle overload among the causes of hospital readmission of COPD patients. Chest 133:4 (2008), 941–947.
25. [25] Kocks, J.W., van den Berg, J.W., Kerstjens, H.A., Uil, S.M., Vonk, J.M., de Jong, Y.P., et al. Day-to-day measurement of patient-reported outcomes in exacerbations of chronic obstructive pulmonary disease. Int. J. chronic Obstr. Pulm. Dis. 8 (2013), 273–286.
26. [26] Garcia-Aymerich, J., Farrero, E., Felez, M.A., Izquierdo, J., Marrades, R.M., Anto, J.M., Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. Thorax 58:2 (2003), 100–105.
27. [27] Steer, J., Gibson, J., Bourke, S.C., The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax 67:11 (2012), 970–976.
28. [28] Almagro, P., Soriano, J.B., Cabrera, F.J., Boixeda, R., Alonso-Ortiz, M.B., Barreiro, B., et al. Short- and medium-term prognosis in patients hospitalized for COPD exacerbation: the CODEX index. Chest 145:5 (2014), 972–980.
29. [29] Donaldson, G.C., Law, M., Kowlessar, B., Singh, R., Brill, S.E., Allinson, J.P., et al. Impact of prolonged exacerbation recovery in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 192:8 (2015), 943–950.